Antivirals
Currently, there are various chemical drugs and interferons, but there are many clinical limitations to these.
In developed countries such as the United States, they have recently begun to perceive the possibility of drugs with excellent effects, which are complex substances. However, a method hasn’t been invented to purify the material yet.
Our headquarter has been researching for over a decade and has already made VSF (Virus Suppressing Factor), which has been patented at home and abroad.
Chemicals have a problem of increased resistance when used continuously, and interferon is used against many kinds of viruses, but the effect is very limited.
Antiviral drug
Currently, the antiviral market is around 30 trillion won.
However, the vast majority of intractable diseases are viral diseases and the growth potential of the antiviral market is very high.
Existing antiviral products are still in the early stages of the market. For example, chemicals can only be used locally for increased tolerance and side effects.
Despite its low drug efficacy, interferon has a market of around 11 trillion won. In the future, we will develop new market for new antiviral drug development,
The market is expected to expand greatly to over 100 trillion won.
What is VSF?
As with interferon, VSF is an in vivo product, yet it has shown remarkable efficacy in comparison with interferon against various viruses in animal experiments.
Moreover, the development of new drugs through clinical trials is likely to solve the limitations of existing drugs and interferon.
This technology is expected to be at least five years ahead of the US market, and VSF is expected to become a new drug in the not too distant future, leading the world market.
VSF Features and Benefits
- Strong viral inhibition in the body and in vitro
- Because it is secreted from the body, it has little side effects and immunity is rarely built.
- By using congenital immunity and acting on cells, it inhibits various viruses
- Because it is composed of complex materials, it is very unlikely to be discovered or developed by other researchers
- Only affect virus-infected cells
- Anti-inflammatory ability to inhibit immune cell infiltration
CureVIS
Antibody protein helps to improve and moisturize skin.
Capacity 10ml / 0.34 fl oz
R&D Manufacturer
ImmuneMed Inc.
Main Ingredient Producer
LONZA, U.K.
Manufacturer
KOLMAR KOREA
- + Antivirals(VSF)
-
Antivirals
Currently, there are various chemical drugs and interferons, but there are many clinical limitations to these.
In developed countries such as the United States, they have recently begun to perceive the possibility of drugs with excellent effects, which are complex substances. However, a method hasn’t been invented to purify the material yet.
Our headquarter has been researching for over a decade and has already made VSF (Virus Suppressing Factor), which has been patented at home and abroad.
Chemicals have a problem of increased resistance when used continuously, and interferon is used against many kinds of viruses, but the effect is very limited.Antiviral drug
Currently, the antiviral market is around 30 trillion won.
However, the vast majority of intractable diseases are viral diseases and the growth potential of the antiviral market is very high.
Existing antiviral products are still in the early stages of the market. For example, chemicals can only be used locally for increased tolerance and side effects.
Despite its low drug efficacy, interferon has a market of around 11 trillion won. In the future, we will develop new market for new antiviral drug development,
The market is expected to expand greatly to over 100 trillion won.What is VSF?
As with interferon, VSF is an in vivo product, yet it has shown remarkable efficacy in comparison with interferon against various viruses in animal experiments.
Moreover, the development of new drugs through clinical trials is likely to solve the limitations of existing drugs and interferon.
This technology is expected to be at least five years ahead of the US market, and VSF is expected to become a new drug in the not too distant future, leading the world market.VSF Features and Benefits
- Strong viral inhibition in the body and in vitro
- Because it is secreted from the body, it has little side effects and immunity is rarely built.
- By using congenital immunity and acting on cells, it inhibits various viruses
- Because it is composed of complex materials, it is very unlikely to be discovered or developed by other researchers
- Only affect virus-infected cells
- Anti-inflammatory ability to inhibit immune cell infiltration
- + CureVIS
-
CureVIS
Antibody protein helps to improve and moisturize skin.
Capacity 10ml / 0.34 fl ozR&D Manufacturer
ImmuneMed Inc.
Main Ingredient Producer
LONZA, U.K.
Manufacturer
KOLMAR KOREA